(EBNK) Evolve European Banks - Ratings and Ratios
European, Bank, Stocks
Description: EBNK Evolve European Banks
The Evolve European Banks Enhanced Yield ETF Hedged CAD (EBNK) is a Canadian ETF that focuses on the financial services sector, specifically targeting European banks. It is designed to provide investors with exposure to the European banking industry while hedging against currency fluctuations to minimize the impact of exchange rate changes on the investment.
From a technical analysis perspective, EBNK has shown a positive trend, with its last price of $13.88 being above its 20-day Simple Moving Average (SMA) of $13.23 and 50-day SMA of $12.80, indicating a short to medium-term bullish sentiment. The 200-day SMA at $11.23 suggests a long-term uptrend. The Average True Range (ATR) of 0.36, or 2.59%, indicates moderate volatility. The ETF is currently near its 52-week high of $13.90, having more than recovered from its 52-week low of $9.32.
Fundamentally, the Assets Under Management (AUM) for EBNK stand at $14.47 million CAD, indicating a relatively small but still viable fund. The ETF tracks the Morningstar Global Financial Services Gross Return CAD Index, providing a diversified portfolio of financial services companies, primarily European banks.
Combining both technical and fundamental analysis, a forecast for EBNK could be cautiously optimistic. The technical indicators suggest a continued uptrend, supported by the ETFs position above its key moving averages. However, the relatively small AUM might be a concern for some investors, potentially impacting liquidity. If the European banking sector continues to recover and the current technical uptrend persists, EBNK could potentially reach new highs, possibly targeting the $15 range in the short to medium term, assuming the ATR remains stable and theres no significant downturn in the global financial services sector.
Investors should closely monitor the performance of European banks, overall market conditions, and any changes in the ETFs AUM and tracking index. A sustained increase in AUM could enhance liquidity and stability, while a decline could signal potential issues. The hedging strategy against CAD also adds a layer of protection, making EBNK a potentially attractive option for investors seeking exposure to European financial services with managed currency risk.
Additional Sources for EBNK ETF
EBNK ETF Overview
Market Cap in USD | 11m |
Category | Financial Services Equity |
IPO / Inception | 2022-01-07 |
EBNK ETF Ratings
Growth Rating | 77.1 |
Fundamental | - |
Dividend Rating | 93.2 |
Rel. Strength | 14.1 |
Analysts | - |
Fair Price Momentum | 15.89 CAD |
Fair Price DCF | - |
EBNK Dividends
Dividend Yield 12m | 13.28% |
Yield on Cost 5y | 22.66% |
Annual Growth 5y | 28.49% |
Payout Consistency | 100.0% |
Payout Ratio | % |
EBNK Growth Ratios
Growth Correlation 3m | 81.9% |
Growth Correlation 12m | 95.3% |
Growth Correlation 5y | 95.9% |
CAGR 5y | 21.13% |
CAGR/Max DD 5y | 0.68 |
Sharpe Ratio 12m | 0.92 |
Alpha | 31.37 |
Beta | 0.690 |
Volatility | 21.86% |
Current Volume | 35.2k |
Average Volume 20d | 19k |
Stop Loss | 13.3 (-3.5%) |
As of July 12, 2025, the stock is trading at CAD 13.78 with a total of 35,235 shares traded.
Over the past week, the price has changed by +0.51%, over one month by +1.74%, over three months by +17.84% and over the past year by +42.98%.
Yes. Based on ValueRay's Analyses, Evolve European Banks (TO:EBNK) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 77.07 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EBNK is around 15.89 CAD . This means that EBNK is currently undervalued and has a potential upside of +15.31% (Margin of Safety).
Evolve European Banks has no consensus analysts rating.
According to our own proprietary Forecast Model, EBNK Evolve European Banks will be worth about 18.2 in July 2026. The stock is currently trading at 13.78. This means that the stock has a potential upside of +31.86%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 18.2 | 31.9% |